ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

• Status: Completed
• Trial end date: 2006-05-01

Summary

The purpose of this study was to assess the difference in disease-free survival between post-menopausal women with hormone receptor-positive early breast cancer who switched from tamoxifen to anastrozole and those who continued on tamoxifen.

• Phase: Phase 3

Details

• Lead Sponsor: AstraZeneca
• Collaborator: Institute of Cancer Research, United Kingdom
• Treatments: Anastrozole; Tamoxifen